Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,934 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
Startale Group announces a $63 million Series A backed by SBI Group and Sony Innovation Fund to accelerate Strium, it...
Most people know estate planning is important, but few take the steps needed to protect loved ones. This article brea...
New Hampshire lawmakers pivot from a sweeping pro-housing mandate to targeted reforms after local pushback. HB1010 mo...
A high-stakes clash between Ray Dalio and Michael Saylor drives a renewed bitcoin price analysis as markets digest Bi...
A pivotal moment in monetary policy unfolds as Warsh is confirmed to lead the Fed, with investors weighing how his st...
Citi raises AMD's price target to $460 on a $132B CPU forecast through 2030, but keeps a Neutral rating, signaling th...
A Buffett-inspired AI model forecasts XRP price paths through 2026, with a base around $2.50 and an all-time high nea...
Tech firms push AI deeper into operations even as layoffs rise. The result is growing anxiety among workers about job...
Roundhill's DRAM ETF, with a 49% Korea weighting, has surged but faces overnight gaps as half its holdings trade when...